Valvular & structural heart disease

Tricuspid Valve Academic Research Consortium-2 (TVARC-2)): Trial Design and Endpoints

J Am Coll CardiolPublished Academic Research Consortium document

Recommendations

As issued by the authors

  1. Defines specific trial design and endpoint options for comparisons of emerging technologies, tricuspid valve surgery and medical therapy

Original publication

Tricuspid Valve Academic Research Consortium-2 (TVARC-2)): Trial Design and Endpoints. J Am Coll Cardiol. Published 21 April 2026. doi:10.1016/j.jacc.2026.02.5102

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.